Heating Compensation Applications Open October 1st: Will Recipients Decrease? ↗
Front page leadApplications for heating compensation will be accepted starting October 1st, raising questions about whether the number of recipients will be reduced.
Moldova
The NewsMaker website from Moldova features a mix of domestic and international news. Top stories include applications for heating compensation, potential Ukrainian product storage in Moldova, and Ukraine's proposal to reduce water discharge into the Dniester River, impacting Chisinau. Other…
Applications for heating compensation will be accepted starting October 1st, raising questions about whether the number of recipients will be reduced.
According to RBC-Ukraine, Kyiv is exploring the possibility of storing products in Moldova, though the Moldovan government states no such discussions are currently underway.
Ukraine has proposed nearly tripling the reduction of water discharge into the Dniester River, prompting concerns about water availability for Chisinau.
A video report shows the bustling harvest season at the Central Market, with prices for tomatoes at 6 and peppers at 5.
A video shows Transnistrian residents protesting against the cancellation of tax benefits by the Moldovan authorities in Chisinau.
NATO fighter jets shot down a drone over Lithuania, with initial reports suggesting it originated from Belarus.
This 'NM Espresso' digest covers the worsening situation on the Dniester, Ukraine's interest in storage facilities in Moldova, and significant earnings of state enterprise directors.
An investigation reveals the substantial earnings of heads of state-owned enterprises such as the airport, Energocom, and Moldtelecom in 2025.
Former US President Trump stated that Russia and Ukraine have reached an agreement to refrain from attacking each other's energy infrastructure.
The government supports an initiative by a PAS party deputy to increase transparency in the selection process for Constitutional Court judges.
The Ministry of Health has apologized to patients, announcing that a crucial cancer treatment drug will once again be available at the Oncology Institute.